Research

MAbImprove reviews the most advanced anti-CoVID-19 monoclonal antibodies

Read more

A MAbImprove team successful in the Gates Foundation Grand Challenge

Read more

A MAbImprove team successful in the INCa-DGOS call!

Read more

Recherche

First-in-­human phase I study for SurgiMab’s molecule SGM-­101 launched in Montpellier Cancer Institute.

Read more

1